Chemoinformaics analysis of 2,3-EPOXYGERIANIAL
Molecular Weight | 168.236 | nRot | 4 |
Heavy Atom Molecular Weight | 152.108 | nRig | 5 |
Exact Molecular Weight | 168.115 | nRing | 1 |
Solubility: LogS | -2.3 | nHRing | 1 |
Solubility: LogP | 2.284 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 28.9727 |
nHD | 0 | BPOL | 18.6553 |
QED | 0.365 |
Synth | 4.144 |
Natural Product Likeliness | 2.871 |
NR-PPAR-gamma | 0.63 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.01 |
Pgp-sub | 0.002 |
HIA | 0.007 |
CACO-2 | -4.435 |
MDCK | 0.0000235 |
BBB | 0.989 |
PPB | 0.529225 |
VDSS | 2.284 |
FU | 0.370689 |
CYP1A2-inh | 0.063 |
CYP1A2-sub | 0.314 |
CYP2c19-inh | 0.031 |
CYP2c19-sub | 0.813 |
CYP2c9-inh | 0.012 |
CYP2c9-sub | 0.083 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.211 |
CYP3a4-inh | 0.045 |
CYP3a4-sub | 0.263 |
CL | 16.029 |
T12 | 0.56 |
hERG | 0.018 |
Ames | 0.733 |
ROA | 0.016 |
SkinSen | 0.955 |
Carcinogencity | 0.331 |
EI | 0.968 |
Respiratory | 0.488 |
NR-Aromatase | 0.035 |
Antiviral | No |
Prediction | 0.921814 |